ARCG:LSE ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP

GBX 366.75 +6.78 ( +1.88)%
Icon

ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP (ARCG:LSE) Stock Analysis and Price Targets

ETF | Others | LSE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 366.75

+6.78 (+1.88)%

GBX 3.68M

0.01M

N/A

N/A

Icon

ARCG:LSE

ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP (GBX)
ETF | LSE
GBX 366.75
+6.78 ( +1.88)%
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 3.68M

N/A

GBX 366.75

ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP (ARCG:LSE) Stock Forecast

N/A

Based on the ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP stock forecast from 0 analysts, the average analyst target price for ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP is not available over the next 12 months. ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP is Very Bearish, which is based on 0 positive signals and 1 negative signals. At the last closing, ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP’s stock price was GBX 366.75. ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP’s stock price has changed by +7.81% over the past week, +4.82% over the past month and 0% over the last year.

No recent analyst target price found for ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP
No recent average analyst rating found for ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP

Company Overview ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP

http://www.ark-invest.com

N/A

N/A

N/A

GBX

UK

N/A

N/A

N/A

N/A

Adjusted Closing Price for ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP (ARCG:LSE)

Loading...

Unadjusted Closing Price for ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP (ARCG:LSE)

Loading...

Share Trading Volume for ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP Shares

Loading...

Compare Performance of ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ARCG:LSE

Top Sectors

N/A

Top Regions

N/A

Valuation Growth & Performance

  • N/A

  • Morningstar Gbl Health TME ...

  • N/A

  • 0.00

  • 0.00

  • 0.00

  • 0.00%

  • 0.00%

  • 0.00%

  • 0%

Stocks Similar To ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP (Sector: Others )

Symbol Name Mer Price(Change) Market Cap
XNID:LSE
Xtrackers Nifty 50 Swap UCITS .. 0.85 % -2.10 (-0.75%) GBX292,109.69B

Frequently Asked Questions About ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP (ARCG:LSE) Stock

Stock Target Advisor's fundamental analysis for ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP's stock is Very Bearish.

Unfortunately we do not have enough data on ARCG:LSE's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on ARCG:LSE's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on ARCG:LSE's stock to indicate if its overvalued.

The last closing price of ARCG:LSE's stock was GBX 366.75.

The most recent market capitalization for ARCG:LSE is GBX 3.68M.

Unfortunately we do not have enough analyst data on ARCG:LSE's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP's stock.

Sorry, we do not have any data on the number of employees for ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP.

Sorry we do not have any infomation available on ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP (ARCG:LSE) Stock

Stock Target Advisor's fundamental analysis for ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP's stock is Very Bearish.

Unfortunately we do not have enough data on ARCG:LSE's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on ARCG:LSE's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on ARCG:LSE's stock to indicate if its overvalued.

The last closing price of ARCG:LSE's stock was GBX 366.75.

The most recent market capitalization for ARCG:LSE is GBX 3.68M.

Unfortunately we do not have enough analyst data on ARCG:LSE's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP's stock.

Sorry, we do not have any data on the number of employees for ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP.

Sorry we do not have any infomation available on ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP's address.
Loading...